11.00
a.m. – 12.30 p.m. |
SYMPOSIUM SPONSORED BY ASTRAZENECA |
|
|
|
Improving
the management of dyslipidemic patients:
LDL lowering and beyond
Co-chair
by: J.-C. Fruchart
(France) & J. Shepherd
(UK) |
|
 |
|
Statins
in coronary patients with diabetes
or metabolic syndrome ..............................................
J.-C. Fruchart (France) |
|
|
| |
|
Optimal
cardiovascular risk reduction:
LDL-C versus ApoB/ApoA1
ratio targets...........................................................................
J. Kastelein (The Netherlands) |
|
|
| |
|
Effects
of statins in acute coronary
syndrome:
focus on diabetic patients
..........................................................................................................
J.-M. Lablanche (France) |
|
|
| |
|
Achieving
lipid goals in high risk patients.................................................................................................
J. Shepherd (UK) |
|
|
|
